---

Osteosarcoma: A review

---

Review Article

Author Details : A.G. Nerkar*

Volume : 3, Issue : 4, Year : 2021

Article Page : 35-37

https://doi.org/10.18231/j.ctppc.2021.010

Suggest article by email

Get Permission

---

Abstract

Osteosarcoma (OS) is a type of cancer with onset in late childhood and peak at early adolescence. OS is a typically is chemo sensitive cancer. The treatment modalities include neo-adjuvant and adjuvant therapies with definitive surgery. Permutations and combinations of chemotherapeutics agents have been used. However, in many clinical trial high dose methotrexate has been used as main drug with cisplatin and doxorubicin (MAP). In recent years, case studies have cited addition of fourth drug to the three drug regimen gives a detail of drug regimen being used over past years and discusses the successful treatment.

Keywords: Methotrexate, Ifosfamide, Cisplatin

How to cite : Nerkar A, Osteosarcoma: A review. Curr Trends Pharm Pharm Chem 2021;3(4):35-37

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.